June Industries Share Price
6.41+0.00 (+0.00%)
+21.17% past 1 Year
Corporate filings & documents
Announcements
Newspaper Publication
1 month agoNewspaper Publication
1 month agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoVoting Results with Scrutinizer Report
1 month agoVoting Results with Scrutinizer Report
1 month agoProceedings of 32nd AGM
1 month agoProceedings of 32nd AGM
1 month agoProceedings of 32nd AGM
1 month agoProceedings of 32nd AGM
1 month agoJune Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Quarterly Results June 30 2026
1 month agoJune Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Quarterly Results June 30 2026
1 month agoNewspaper Publication
2 months agoNewspaper Publication
2 months agoAnnual Report 2025-2026
2 months agoAnnual Report 2025-2026
2 months agoAGM
2 months agoAGM
2 months agoReg 74(5)
2 months agoReg 74(5)
2 months agoAGM
2 months agoAGM
2 months agoJune Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 inter alia to consider and approve AGM
2 months agoJune Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 inter alia to consider and approve AGM
2 months agoClosure of Trading Window for the quarter ended June 30 2026
3 months agoClosure of Trading Window for the quarter ended June 30 2026
3 months agoNewspaper Publication of Audited Financial Results for the year ended March 31 2026
4 months agoAudited Financial Results along with Auditors Report for the year ended March 31 2026
4 months agoAudited Financial Results along with Auditors Report for the year ended March 31 2026
4 months agoJune Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 inter alia to consider and approve Audited Results along with Auditors Report for the financial year ended March 31 2026
4 months agoDisclosure under Regulation 32(1) of SEBI (LODR) Regulations 2015
4 months agoDisclosure under Regulation 32(1) of SEBI (LODR) Regulations 2015
4 months agoKashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve Adopt and Approve Audited financial result for the quarter and financial year ended on 31st March 2026 along with the Auditors Report
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kashyap Tele-Medicines Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L29110MH1995PLC085738</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Varsha Ninad Sawant <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Anirudh Virendrakumar Shah <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 14/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kashyap Tele-Medicines Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L29110MH1995PLC085738</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Varsha Ninad Sawant <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Anirudh Virendrakumar Shah <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 14/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months agoCertificate from RTA under Reg 74(5)
5 months agoCertificate from RTA under Reg 74(5)
5 months agoClosure of Trading Window
6 months agoClosure of Trading Window
6 months agoIndependent Directors Meeting
6 months agoIndependent Directors Meeting
6 months agoKashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 inter alia to consider and approve Independent Directors Meeting
6 months agoPublication of Standalone Un-Audited Financial Results for Third Quarter and Nine Months ended on December 31 2025 in Newspaper.
7 months agoUn-Audited Financial Results for the Third Quarter and Nine Months ended December 31 2025 along with the Statutory Auditors Limited review report
7 months agoUn-Audited Financial Results (UFR) for the Third quarter and Nine months ended December 31 2025 along with the Statutory Auditors Limited Review Report
7 months agoKashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Unaudited results for quarter ended December 31 2025
8 months agoThis is in continuation of the Corporate Announcements submitted by the Company on August 14 2025 under Reg 30 of the SEBI (LODR) Regulations 2015 intimating the resignation of Directors and pursuant to the email directions received from BSE Limited seeking additional details in terms of SEBI circular no SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024.
8 months agoRegulation 74(5) along with RTAs certificate
8 months agoAnnual reports
Concalls & investor presentations
No presentations found